One in Five Wet AMD Patients Discontinue Treatment Without Explanation in Canadian Study
Source Summary
A large multicenter Canadian cohort study found that 527 of 2,556 patients (approximately 20%) receiving treatment for neovascular wet age-related macular degeneration (AMD) discontinued care without explanation during long-term follow-up. The study identified predictors associated with loss of follow-up in this patient population.
Why it matters
High rates of unexplained treatment discontinuation in wet AMD patients may compromise vision outcomes and indicate a need to identify and address barriers to sustained care adherence.
